Primary record
(8ss)-N-[3-(dimethylamino)propyl]-6-(2-propen-1-yl)ergoline-8-carboxamide; FCE 21590; (6aR,9R,10aR)-N-[3-(Dimethylamino)propyl]-7-(prop-2-enyl)-4,6,6a,7,8,9,10,10a-octahydroindolo[4,3-fg]quinoline-9-carboxamide; Cabergoline Imp. D (EP)
- 库存
- 9,025 克
- 纯度
- 99.6 %
- CAS
- 85329-86-8
化合物标识与属性
- CAS
- 85329-86-8
- PubChem CID
- 10927015
- SMILES
- CN(C)CCCNC(=O)[C@@H]1C[C@H]2[C@@H](CC3=CNC4=CC=CC2=C34)N(C1)CC=C
- Canonical SMILES
- C=CCN1C[C@H](C(=O)NCCCN(C)C)C[C@@H]2c3cccc4[nH]cc(c34)C[C@H]21
名称与同义词
- Desethylcarbamoyl Cabergoline
- Cabergoline EP Impurity D
- Cabergoline Impurity D
- UNII-114UFJ65CL
- Cabergoline specified impurity D
- 85329-86-8
- Cabergoline related compound D
- RefChem:161885
- 114UFJ65CL
- FCE-21590
- DTXSID40234529
- Cabergoline related compound D [USP]
- SCHEMBL1891628
- DTXCID20157020
- FCE 21590
- JJTHJEHDIBAMMM-YFVAEKQCSA-N
- ZINC35643766
- Cabergoline related compound D (USP)
- FD21184
- CABERGOLINE IMPURITY D [EP IMPURITY]
- CID10927015
- N-(3-(Dimethylamino)propyl)-6-(2-propenyl)-ergoline-8-carboxamide, (8beta)-
- CID 10317664
- J780.892E
- CABERGOLINE IMPURITY D (EP IMPURITY)
- FT-0665946
- CABERGOLINE RELATED COMPOUND D [USP IMPURITY]
- CABERGOLINE RELATED COMPOUND D (USP IMPURITY)
- N-[3-(dimethylamino)propyl]-6-allylergoline-8beta-carboxamide
- Q27251253
- (6aR,9R,10aR)-N-(3-(Dimethylamino)propyl)-7-(prop-2-enyl)-4,6,6a,7,8,9,10,10a-octahydroindolo(4,3-fg)quinoline-9-carboxamide
- (6aR,9R,10aR)-N-[3-(dimethylamino)propyl]-7-prop-2-enyl-6,6a,8,9,10,10a-hexahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide
- Ergoline-8-carboxamide, N-(3-(dimethylamino)propyl)-6-(2-propenyl)-, (8beta)-
- B0497-467953
- ERGOLINE-8-CARBOXAMIDE, N-(3-(DIMETHYLAMINO)PROPYL)-6-(2-PROPENYL)-, (8.BETA.)-
- N-(3-(DIMETHYLAMINO)PROPYL)-6-(2-PROPENYL)-ERGOLINE-8-CARBOXAMIDE, (8.BETA.)-
- (5R,8R,10R)-6-Allyl-N-[3-(dimethylamino)propyl]ergoline-8- carboxamide
- (5R,8R,10R)-6-Allyl-N-[3-(dimethylamino)propyl]ergoline-8-carboxamide
- (8beta)-N-(3-(dimethylamino)propyl)-6-(2-propenyl)-ergoline-8-carboxamide
- N-[3-(Dimethylamino)propyl]-6-(2-propenyl)ergoline-8beta-carboxamide
- N-[3-(Dimethylamino)propyl]-6-(prop-2-en-1-yl)ergoline-8beta-carboxamide
- N-[3-(Dimethylamino)propyl]-6-(2-propen-1-yl)-(8|A)-ergoline-8-carboxamide
- N-[3-(Dimethylamino)propyl]-6-(2-propen-1-yl)-(8b)-ergoline-8-carboxamide
- N-[3-(Dimethylamino)propyl]-6-(2-propen-1-yl)-(8beta)-ergoline-8-carboxamide
- (2R,4R,7R)-N-[3-(dimethylamino)propyl]-6-(prop-2-en-1-yl)-6,11-diazatetracyclo[7.6.1.02,7.012,16]hexadeca-1(16),9,12,14-tetraene-4-carboxamide
- (6aR,9R,10aR)-7-allyl-N-(3-(dimethylamino)propyl)-4,6,6a,7,8,9,10,10a-octahydroindolo[4,3-fg]quinoline-9-carboxamide
- (8ss)-N-[3-(dimethylamino)propyl]-6-(2-propen-1-yl)ergoline-8-carboxamide; FCE 21590; (6aR,9R,10aR)-N-[3-(Dimethylamino)propyl]-7-(prop-2-enyl)-4,6,6a,7,8,9,10,10a-octahydroindolo[4,3-fg]quinoline-9-carboxamide; Cabergoline Imp. D (EP)